Your donation will make a difference:
Cystic Fibrosis Trust
Forum
  • Home
  • /
  • Home
  • /
  • News
  • /
  • Trials Accelerator expands network of CF centres

Trials Accelerator expands network of CF centres

The Trust’s Clinical Trials Accelerator Platform is growing its network of UK cystic fibrosis (CF) centres through a collaborative new scheme, expanding clinical trial accessibility for the CF community.

Map of Clinical Trials Accelerator Platform centres across UK: Glasgow, Edinburgh, Newcastle, Belfast, Blackpool, Middlesborough, Leeds, Manchester, Sheffield, Liverpool, Nottingham, Leicester, Norfolk & Norwich, Stoke-on-trent, Birmingham, Cambridge, Oxford, Cardiff, Bristol, London, Exeter, and SouthamptonNine UK CF centres have been selected to join the Trials Accelerator’s growing network in the new ‘Affiliate Centre’ scheme, with the aim to increase access and participation of high priority CF clinical trials.

Affiliate Centres will be recognised as members of the Trials Accelerator and will work alongside other participating centres to recruit people with CF to clinical trials. This collaborative approach will further establish the UK as a desirable place for pharmaceutical companies to invest new treatments for CF, ensuring the UK CF community have access to a wider choice of new and developing therapies through clinical trials.

The new scheme is inclusive of CF centres with varying clinical trial experience, giving those with minimal trial experience the opportunity to develop a CF trial portfolio and be supported by larger, more experienced centres. Affiliate Centres will also be invited to bi-annual workshops and training opportunities alongside current Trial Accelerator centres.

The CF centres who have joined as Affiliate Centres include:

  • South Tees NHS Foundation Trust (Middlesborough) - Paediatric
  • NHS Lothian (Edinburgh) - Paediatric
  • The Newcastle-upon-Tyne Hospitals NHS Foundation Trust - Adult
  • Sheffield Children's Hospital NHS Foundation Trust - Paediatric
  • University Hospitals of Leicester NHS Trust - Paediatric & Adult
  • Blackpool Teaching Hospitals NHS Foundation Trust - Adult
  • University Hospitals of North Midlands (Stoke) - Paediatric & Adult
  • Oxford University Hospitals NHS Foundation Trust - Paediatric & Adult

Man with dark brown hair, glasses, wearing blue collared shirt underneath red v jumperProfessor Cunningham from NHS Lothian, said: “We were not able to join the Trials Accelerator at its outset and so are delighted to be joining now. We endeavour to support our patients by providing them with the best opportunities for new therapies as they come to clinical trials. Working within the Trials Accelerator will help us deliver these aims, and the team here in Edinburgh are relishing the prospect!”

man with black hair wearing sweater-vest and pink collared shirt

Dr Saba from the Blackpool Teaching Hospitals said: "As the UK's newest adult CF centre, we are keen to give our patients the chance to take part in cutting-edge research. Being part of the scheme means we will be among the first to hear about new research studies, and we look forward to helping the Trust ensure the success of this important work."

The nine Affiliate Centres (pictured) were selected based on demonstrable enthusiasm for clinical trials and local infrastructure to supportdelivery. Collectively, the 29 centres who form the Trials Accelerator cover over 80% of the UK CF population, empowering the CF community by involving them in shaping the future of treatments.

Stay in touch to hear about clinical trials with our quarterly clinical trials newsletter or keep an eye on new trials via the CF Trials Tracker









Related content

  • Triple timeline announced by NICE

    Yesterday, NICE announced its planned timelines for assessing the triple combination therapy, with 16 December 2020 the date they expect to publish...

  • Research Blast on... Antimicrobial Resistance

    Q Why are infection-causing bugs in the CF lungs like characters in the film ‘Minions’? A They’re always talking amongst themselves and plotting...

  • Access to medicines starts with clinical trials

    Completed trials for those aged 12 and above Initially, separate trials for Vertex’s Kaftrio were set up to assess its suitability for people...

  • Clinical trials

    14 July 2020: Due to COVID-19 some cystic fibrosis (CF) clinical trials may still be temporarily paused, however some trials will begin to re-open...